1. Home
  2. CHRO vs BREA Comparison

CHRO vs BREA Comparison

Compare CHRO & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHRO
  • BREA
  • Stock Information
  • Founded
  • CHRO 2002
  • BREA 2022
  • Country
  • CHRO United States
  • BREA Ireland
  • Employees
  • CHRO N/A
  • BREA N/A
  • Industry
  • CHRO
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • CHRO
  • BREA Consumer Discretionary
  • Exchange
  • CHRO Nasdaq
  • BREA Nasdaq
  • Market Cap
  • CHRO 10.7M
  • BREA 8.7M
  • IPO Year
  • CHRO 2024
  • BREA 2023
  • Fundamental
  • Price
  • CHRO $1.45
  • BREA $0.69
  • Analyst Decision
  • CHRO Strong Buy
  • BREA
  • Analyst Count
  • CHRO 1
  • BREA 0
  • Target Price
  • CHRO N/A
  • BREA N/A
  • AVG Volume (30 Days)
  • CHRO 8.2K
  • BREA 260.2K
  • Earning Date
  • CHRO 03-27-2025
  • BREA 01-03-2025
  • Dividend Yield
  • CHRO N/A
  • BREA N/A
  • EPS Growth
  • CHRO N/A
  • BREA N/A
  • EPS
  • CHRO N/A
  • BREA N/A
  • Revenue
  • CHRO N/A
  • BREA $2,872,101.00
  • Revenue This Year
  • CHRO N/A
  • BREA N/A
  • Revenue Next Year
  • CHRO N/A
  • BREA N/A
  • P/E Ratio
  • CHRO N/A
  • BREA N/A
  • Revenue Growth
  • CHRO N/A
  • BREA 2338.69
  • 52 Week Low
  • CHRO $0.45
  • BREA $0.50
  • 52 Week High
  • CHRO $3.80
  • BREA $1.95
  • Technical
  • Relative Strength Index (RSI)
  • CHRO 43.38
  • BREA 51.42
  • Support Level
  • CHRO $1.34
  • BREA $0.65
  • Resistance Level
  • CHRO $2.00
  • BREA $0.76
  • Average True Range (ATR)
  • CHRO 0.17
  • BREA 0.06
  • MACD
  • CHRO -0.02
  • BREA 0.00
  • Stochastic Oscillator
  • CHRO 16.58
  • BREA 53.28

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: